» Articles » PMID: 38863743

A Standardized Combination of and Extracts Enhances Immune Function in Adults: a Pilot Randomized, Double-blind, Placebo-controlled Clinical Study

Overview
Journal Food Nutr Res
Date 2024 Jun 12
PMID 38863743
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The use of botanical medicine has been demonstrated as a potential strategy to manage or treat a variety of health issues. (Retz) fruit and (L.) Dunal roots are important medicinal herbs described in Ayurveda and traditional therapy for diverse health benefits.

Objective: This pilot study aimed to evaluate the immune function-enhancing potential of a unique blend of fruit and root extracts, LN20189, in healthy men and women.

Methods: Forty healthy volunteers (age: 35-60 years) were randomized into two groups receiving either LN20189 (500 mg per day) or a matched placebo over 28 consecutive days. The total T-cell population was the primary efficacy measure in this study. The secondary efficacy measures included counts of CD4, CD8, natural killer (NK) cells, serum levels of interleukin-2 (IL-2), interferon-gamma (IFN-γ), total immunoglobulin-G (IgG), and Immune Function Questionnaire (IFQ) scores. Safety parameter assessments were also conducted.

Results: Post-trial, in LN20189-supplemented subjects, T cells, CD4, NK cells count, and the CD4:CD8 ratio were increased by 9.32, 10.10, 19.91, and 17.43%, respectively, as compared to baseline. LN20189 supplementation increased serum IFN-γ and IgG levels by 14.57 and 27.09% from baseline and by 13.98 and 21.99%, compared to placebo, respectively. Also, the IFQ scores in the LN20189 group were 84.68% (vs. baseline) and 69.44% (vs. placebo) lower at the end of the trial. LN20189 improved the study volunteers' cellular and humoral immune functions.

Conclusion: In summary, LN20189 supplementation was found tolerable and improved the key cellular and humoral factors of the immune system and helped improve immune function of the trial volunteers.

References
1.
Lo Nigro C, Macagno M, Sangiolo D, Bertolaccini L, Aglietta M, Merlano M . NK-mediated antibody-dependent cell-mediated cytotoxicity in solid tumors: biological evidence and clinical perspectives. Ann Transl Med. 2019; 7(5):105. PMC: 6462666. DOI: 10.21037/atm.2019.01.42. View

2.
Baradaran Rahimi V, Askari V, Shirazinia R, Soheili-Far S, Askari N, Rahmanian-Devin P . Protective effects of hydro-ethanolic extract of Terminalia chebula on primary microglia cells and their polarization (M/M balance). Mult Scler Relat Disord. 2018; 25:5-13. DOI: 10.1016/j.msard.2018.07.015. View

3.
Gautam M, Diwanay S, Gairola S, Shinde Y, Jadhav S, Patwardhan B . Immune response modulation to DPT vaccine by aqueous extract of Withania somnifera in experimental system. Int Immunopharmacol. 2004; 4(6):841-9. DOI: 10.1016/j.intimp.2004.03.005. View

4.
Zhang C, Jiang K, Qu S, Zhai Y, Tan J, Tan C . Triterpenoids from the barks of Terminalia chebula. J Asian Nat Prod Res. 2015; 17(10):996-1001. DOI: 10.1080/10286020.2015.1052803. View

5.
Iuvone T, Esposito G, Capasso F, Izzo A . Induction of nitric oxide synthase expression by Withania somnifera in macrophages. Life Sci. 2003; 72(14):1617-25. DOI: 10.1016/s0024-3205(02)02472-4. View